产品名称
ESHMUNO Q, Eshmuno® Q
ligand
(Trimethylammoniumethyl)
sterility
sterile (Caustic Stable)
product line
Eshmuno®
form
resin
specific analyte(s)
MAbs
parameter
1000 cm/hr flow rate
1000 cm/hr max. flow rate
8 bar max. pressure
matrix active group
polymer, polyvinyl ether
mean particle size
85 μm
capacity
150 mg binding capacity (BSA/mg of resin)
~150 mg, BSA binding capacity
transition temp
flash point 35 °C (own results)
density
1 g/cm3 at 20 °C
application(s)
recombinant protein
vaccine development
separation technique
anion exchange
mixed mode
storage temp.
2-30°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Analysis Note
Microscopic evaluation: Spherical particles, no agglomerates, no fines.
Extractable matter (water): ≤ 0.08 %
Ionic capacity: 90 - 190 µeq/ml
Performance test (conalbumin): 9 - 19 mS/cm
Performance test (human serum albumin): 20 - 30 mS/cm
Pressure drop(column: ID=1.6 cm, L=10 cm at 5 ml/min): ≤ 1.0 bar
Protein binding capacity(bovine serum albumin): 120 - 190 mg/ml
Particle size (50-120 µm): ≥ 80 %
Particle size (d50): 75 - 95 µm
Cerium: ≤ 30 µg/g
Endotoxins: ≤ 1.00 EU/ml
TAMC (total aerobic microbial count): ≤ 100 CFU/ml
TYMC (total yeast and mould count): ≤ 100 CFU/ml
Features and Benefits
- Purification of acidic and neutral proteins and peptides from different sources, including plasma
Superior productivity for downstream processing of biomolecules
- High flow rate versus pressure-flow behavior
- Excellent removal of impurities, such as HCP, leached Protein A, and viruses
- Robust and safe packing procedures
- Strong chemical stability
General description
Packaging
- 1.20079.0100: Eshmuno® Q Resin 100ml
- 1.20079.0010: Eshmuno® Q Resin 10ml
- 1.20079.0500: Eshmuno® Q Resin 500ml
- 1.20079.5000: Eshmuno® Q Resin 5L
Legal Information
signalword
Warning
hcodes
Hazard Classifications
Flam. Liq. 3
存储类别
3 - Flammable liquids
wgk
WGK 1
flash_point_f
95.0 °F
flash_point_c
35 °C
商品
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
Minimize bottlenecks in downstream processing. Discover how flow-through technologies increase speed and efficiency, reducing footprint and costs.
Separation and purification of subpopulations of extracellular vesicles (EVs) using Eshmuno® Q anion exchange resin and Natrix® Q membrane chromatography.
See case study examples of how to optimize chromatographic purification of plasmid DNA for Biopharmaceutical Applications.
相关内容
通过合作进行量身定制的病毒疫苗生产，应对病毒特有的挑战。
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持